What is IQV stock price today?

IQV (Iqvia Holdings Inc) stock is trading at $178.81 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is IQV stock going up or down today?

IQV stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy IQV stock now?

The decision to buy IQV depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is IQV a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for IQV based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is IQV stock overvalued or undervalued?

IQV currently trades at a P/E ratio of 22.84 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if IQV is fairly priced.

What is IQV's P/E ratio?

IQV has a price-to-earnings (P/E) ratio of 22.84, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is IQV's market cap?

IQV (Iqvia Holdings Inc) has a market capitalization of $30.45 billion, making it a mid-cap stock.

What is IQV's price to book ratio?

IQV trades at a price-to-book (P/B) ratio of 4.45, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does IQV pay dividends?

IQV does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is IQV's dividend yield?

IQV does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is IQV stock a good long-term investment?

IQV's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is IQV's revenue growth rate?

IQV has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, IQV is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in IQV?

Key risks for IQV include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does IQV compare to its competitors?

Compare IQV to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize IQV's performance and positioning.

What is IQV's stock price target for 2026?

Our AI model provides price targets for IQV based on fundamental analysis: Bull case $232.45 (+30%), Base case $205.63 (+15%), Bear case $160.93 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about IQV?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for IQV. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is IQV's next earnings report?

IQV reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

IQV - Iqvia Holdings Inc

NYSE * Health Care * Life Sciences Tools & Services

$178.81

+$8.17 (+4.79%)

About Iqvia Holdings Inc

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

IQV Key Statistics

Market Cap

$30.45B

P/E Ratio

22.84

P/B Ratio

4.45

EPS

$7.83

Revenue Growth

+0.1%

Profit Margin

0.1%

Employees

93,000

How IQV Compares to Peers

IQV has the lowest P/E ratio in Life Sciences Tools & Services, suggesting it may be the most undervalued

IQV is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
IQV(This stock)	$30.45B	22.8	0%	0.1%	-
AMZNAmazon Com	$2.23T	29.0	0%	0.1%	vs AMZN

Iqvia Holdings Inc Company Information

Headquarters: North Carolina; U.S.A
Website: www.iqvia.com
Sector: Health Care
Industry: Life Sciences Tools & Services

IQV - Iqvia Holdings Inc

About Iqvia Holdings Inc

IQV Key Statistics

How IQV Compares to Peers

Iqvia Holdings Inc Company Information

IQV Lician Score

IQV Financial Snowflake

Upcoming Events for IQV